Bicycle Therapeutics (BCYC) Non-Current Assets (2018 - 2026)

Bicycle Therapeutics has reported Non-Current Assets for 9 years, with the latest figure at $20.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 31.21% year-over-year to $20.3 million; the trailing twelve-month figure through Mar 2026 stood at $20.3 million (up 31.21% YoY), and the FY2025 full-year result was $21.9 million, up 27.45% from the prior year.
• Non-Current Assets for Q1 2026 stood at $20.3 million, down from $21.9 million in the prior quarter.
• The five-year high for Non-Current Assets was $37.0 million in Q1 2023, with the low at $11.4 million in Q3 2025.
• Historically, Non-Current Assets has averaged $24.5 million across 5 years, with a median of $24.8 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 442.27% — and 2025, when it plunged 44.58%.
• Bicycle Therapeutics' Non-Current Assets stood at $32.8 million in 2022, then retreated by 15.52% to $27.7 million in 2023, then slumped by 37.91% to $17.2 million in 2024, then increased by 27.45% to $21.9 million in 2025, then declined by 7.48% to $20.3 million in 2026.
• The last three Non-Current Assets figures came in at $20.3 million (Q1 2026), $21.9 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.